LYKA LABS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Lyka Labs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-1.02₹ -1.02
As on Sep 22, 2025, 4:01 PM IST
Lyka Labs Price Performance
Today's LowToday's High
₹98.50₹100.32
₹99.07
52 Weeks' Low52 Weeks' High
₹90.20₹175.95
₹99.07
Open Price
₹98.50
Prev. Close
₹100.09
Volume
4,033
Over the last 5 years, the share price of Lyka Labs has gained 39.96% CAGR. Over the past year, the corresponding return has been -33.55%.
Lyka Labs’s current P/E of 47.11x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Lyka Labs Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Lyka Labs | -0.35 | -1.13 | -12.87 | -5.20 | -33.55 | -10.18 | 39.96 |
| Sun Pharmaceutical Industries | 1.72 | 0.58 | -1.20 | -6.06 | -11.87 | 21.54 | 26.69 |
| Divi's Laboratories | 1.09 | 1.45 | -7.55 | 4.61 | 11.77 | 18.79 | 14.03 |
| Cipla | -2.04 | -0.27 | 2.75 | 1.89 | -5.97 | 12.20 | 14.96 |
| Torrent Pharmaceuticals | 2.46 | -0.24 | 15.31 | 13.14 | 5.55 | 34.21 | 22.00 |
| Dr. Reddy's Laboratories | -1.13 | 4.49 | -1.80 | 9.68 | -0.68 | 15.56 | 4.84 |
| Mankind Pharma | 0.63 | 3.62 | 13.42 | 15.59 | 1.93 | 22.16 | 12.76 |
| Zydus Lifesciences | -1.01 | 5.21 | 8.07 | 12.82 | -2.00 | 40.77 | 21.16 |
| Lupin | -1.82 | 3.35 | 3.02 | -3.80 | -6.82 | 44.02 | 14.02 |
| Alkem Laboratories | 0.64 | 1.59 | 14.76 | 11.81 | -9.94 | 18.22 | 13.86 |
| Aurobindo Pharma | 2.13 | 6.87 | 1.98 | -4.81 | -25.32 | 27.96 | 7.16 |
| Abbott India | -2.17 | -7.14 | -3.93 | 0.36 | 7.35 | 18.69 | 13.77 |
| Glenmark Pharmaceuticals | -5.46 | 4.75 | 23.06 | 36.28 | 23.93 | 74.09 | 33.61 |
| Laurus Labs | 0.94 | 3.25 | 38.86 | 49.66 | 93.51 | 19.68 | 25.95 |
| Biocon | -0.86 | 0.72 | 2.94 | 6.14 | -1.00 | 6.66 | -3.34 |
| GlaxoSmithKline Pharmaceuticals | -0.45 | -0.83 | -13.82 | -3.44 | 1.90 | 25.42 | 10.27 |
| Anthem Biosciences | -0.38 | -1.30 | 13.66 | 13.66 | 13.66 | 4.36 | 2.59 |
| Ipca Laboratories | 6.36 | 2.15 | 1.87 | -0.16 | -2.47 | 17.09 | 6.07 |
| Cohance Lifesciences | -8.18 | 0.82 | -8.54 | -24.53 | -25.81 | 24.95 | 18.92 |
| Gland Pharma | -1.03 | 2.89 | 16.17 | 25.81 | 11.37 | -3.52 | 1.90 |
Over the last one year, Lyka Labs has declined 33.55% compared to peers like Sun Pharmaceutical Industries (-11.87%), Divi's Laboratories (11.77%), Cipla (-5.97%). From a 5 year perspective, Lyka Labs has outperformed peers relative to Sun Pharmaceutical Industries (26.69%) and Divi's Laboratories (14.03%).
Lyka Labs Financials
Lyka Labs Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 99.39 | 99.73 |
| 10 | 99.44 | 99.69 |
| 20 | 99.86 | 100.42 |
| 50 | 104.99 | 103.97 |
| 100 | 109.7 | 108.73 |
| 200 | 120.78 | 115.49 |
Lyka Labs Share Holding Pattern
In the latest quarter, Lyka Labs remained same as its previous close in promoter holding, while DII stake unchanged at 0.66%, FII holding fell to 0.16%, and public shareholding moved up to 41.02% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Lyka Labs Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 18, 2025, 10:49 PM IST | Lyka Labs - Update On The Scheme Of Amalgamation |
| Sep 05, 2025, 6:19 AM IST | Lyka Labs - Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Updates |
| Sep 01, 2025, 9:19 PM IST | Lyka Labs - Announcement under Regulation 30 (LODR)-Change in Management |
| Aug 30, 2025, 12:28 AM IST | Lyka Labs - Announcement under Regulation 30 (LODR)-Change in Management |
| Aug 08, 2025, 11:03 PM IST | Lyka Labs - Update On Scheme Of Amalgamation |
About Lyka Labs
Lyka Labs Ltd. is a Public Limited Listed company incorporated on 29/12/1976 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1976PLC008738 and registration number is 008738. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 134.70 Cr. and Equity Capital is Rs. 35.69 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address4801/B & 4802/A, Ankleshwar Gujarat 393002
- Contact
Management
- Mr. Babulal JainChairman
- Mr. Kunal GandhiManaging Director & CEO
- Mr. Yogesh B ShahWholeTime Director & CFO
- Mr. Shashil MendosaNon Executive Director
- Mr. Prashant GodhaNon Executive Director
- Mrs. Dhara ShahIndependent Director
- Mr. Neeraj GolasIndependent Director
- Ms. Archana S YadavIndependent Director
FAQs on Lyka Labs Share Price
What is the share price of Lyka Labs?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Lyka Labs is ₹99.07 as on Sep 22, 2025.
What kind of stock is Lyka Labs?
The Lyka Labs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Lyka Labs?
The market cap of Lyka Labs is ₹353.58 Cr as on Sep 22, 2025.
What are today's High and Low prices of Lyka Labs?
Today’s highest and lowest price of Lyka Labs are ₹100.32 and ₹98.50.
What are the 52 Week High and 52 Week Low of Lyka Labs?
The 52-week high/low is the highest and lowest price at which Lyka Labs stock has traded in the past 52-week or nearly a year. The 52-week high of Lyka Labs is ₹175.95 and 52-week low of Lyka Labs is ₹90.20 as on Sep 22, 2025.
How has the Lyka Labs performed historically in terms of returns?
The Lyka Labs has shown returns of -1.02% over the past day, -1.13% for the past month, -12.87% over 3 months, -33.55% over 1 year, -10.18% across 3 years, and 39.96% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Lyka Labs?
P/E ratio of and PB ratio of Lyka Labs are 47.11 and 3.57 on Sep 22, 2025. While the company gives a dividend yield of 0.00 per annum.
Trending In Market
Mutual Funds Screener
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data